Health Care: Drugs

Exelixis Inc (EXEL: NASDAQ)

$3.1 0.05 | 1.64%
03/05/15 - 01:56 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 25.11M 31.34M 47.45M 289.64M
Cost of Sales 2.04M 1.12M 0.00 0.00
Gross Operating Profit 23.07M 30.22M 47.45M 289.64M
Selling, General, and Administrative Expenses 50.83M 50.96M 31.84M 33.13M
Research & Development 189.10M 178.76M 128.88M 156.84M
Operating Income before D & A (EBITDA) -216.86M -199.50M -113.26M 99.67M
Depreciation & Amortization 31.92M 29.44M 20.47M 6.82M
Interest Income 4.34M 1.22M 1.99M 1.46M
Other Income - Net 0.00 0.00 0.00 2.25M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -252.04M -228.95M -140.92M 86.43M
Interest Expense 48.61M 45.35M 27.09M 16.26M
Pre-Tax Income -300.65M -274.29M -168.01M 70.17M
Income Taxes -182.00K -96.00K 107.00K 1.30M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -268.54M -244.76M -147.64M 75.70M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -268.54M -244.76M -147.64M 75.70M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -268.54M -244.76M -147.64M 75.70M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-260.95M -243.53M -138.47M 85.83M
Preferred Dividends
Net Income Available To Common -268.54M -244.76M -147.64M 75.70M
Basic EPS from Continuing Ops. -1.38 -1.33 -0.92 0.60
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.38 -1.33 -0.92 0.60
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.38 -1.33 -0.92 0.60
Basic Normalized Net Income/Share -1.34 -1.32 -0.86 0.68
EPS fr Continuing Ops. -1.38 -1.33 -0.92 0.58
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.38 -1.33 -0.92 0.58
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.38 -1.33 -0.92 0.58
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.34 -1.32 -0.86 0.66
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with EXEL

Latest EXEL Headlines from TheStreet

More Financial News for EXEL

Press Releases for EXEL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter